PELL Bio-Med Technology CoTPE:6949 -1.77%13 Days Payable is 125.74 as of Dec. 2025, which is 125% above its 10-year median of 56.00. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review. Among 702 Biotechnology companies, PELL Bio-Med Technology Co ranks worse than 67.24% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6949 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, PELL Bio-Med Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PELL Bio-Med Technology Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where PELL Bio-Med Technology Co's Days Payable falls into.
PELL Bio-Med Technology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PELL Bio-Med Technology Co (TPE:6949) has a Days Payable of 125.74 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PELL Bio-Med Technology Co and its competitors. This is 125% above median its historical median of 56.00. Over the past decade, PELL Bio-Med Technology Co's Days Payable has ranged from 51.64 to 65.45. According to the industry distribution chart, PELL Bio-Med Technology Co ranks #472 out of 702 companies in the Biotechnology industry, placing it in the top 67.2%.
Is PELL Bio-Med Technology Co's Days Payable too high?
PELL Bio-Med Technology Co's current Days Payable of 125.74 is 125% above median its 10-year median of 56.00. Over the past 10 years, this metric has ranged from a low of 51.64 to a high of 65.45. The Biotechnology industry median Days Payable is 113.56. PELL Bio-Med Technology Co's value of 125.74 is 10.7% above this industry median. Based on the distribution chart, PELL Bio-Med Technology Co ranks #472 out of 702 companies in the Biotechnology industry, which is below the industry midpoint. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PELL Bio-Med Technology Co ranks #472 out of 702 companies for Days Payable. This places PELL Bio-Med Technology Co in the lower half of its industry. The industry median Days Payable is 113.56. PELL Bio-Med Technology Co's value of 125.74 is 10.7% above this benchmark. Historically, PELL Bio-Med Technology Co's own Days Payable has ranged from 51.64 to 65.45 over the past decade. While the company's 10-year median is 56.00 vs. the industry median of 113.56, PELL Bio-Med Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PELL Bio-Med Technology Co's current Days Payable of 125.74 is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PELL Bio-Med Technology Co and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PELL Bio-Med Technology Co's current Days Payable is 125.74, which is 125% above median its own 10-year median of 56.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current Days Payable of 125.74. The current Days Payable is 125.74, which is 125% above median its 10-year median of 56.00 and 10.7% above the Biotechnology industry median of 113.56. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current Days Payable is 125.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score
Get the complete analysis for TPE:6949
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6949 has been successfully added to your 
